|
|||||
|
|

Investment banking firm Houlihan Lokey (NYSE:HLI) announced better-than-expected revenue in Q3 CY2025, with sales up 14.7% year on year to $659.5 million. Its non-GAAP profit of $1.84 per share was 9.3% above analysts’ consensus estimates.
Is now the time to buy HLI? Find out in our full research report (it’s free for active Edge members).
Houlihan Lokey’s third quarter results were driven by strong execution in its Corporate Finance segment, which benefited from a rebound in M&A activity and improving capital markets. CEO Scott Adelson highlighted that transaction volumes reached their highest levels since late 2021, while contributions from capital solutions remained robust. Management noted that the environment for deal-making improved as macroeconomic volatility and tariff-related uncertainty eased, resulting in increased client confidence and engagement. The firm also pointed to significant growth in its international business, particularly in Europe and Asia Pacific, as a notable contributor this quarter.
Looking ahead, Houlihan Lokey’s leadership emphasized a positive outlook for continued growth, anchored by a healthy deal backlog and expanding international opportunities. Adelson stated, “If conditions remain on the current trajectory, we are well positioned to continue to experience year-over-year growth.” Management expects the Corporate Finance segment to see stronger performance in the fourth quarter, while the restructuring business should remain resilient despite a slight slowdown in new engagements. The company is also banking on new senior hires and a steady acquisition pipeline to drive expansion.
Management attributed the quarter’s performance to a surge in M&A activity, capital availability, and international expansion, while noting a shift in typical business seasonality.
Management expects continued growth, driven by a strong deal backlog, international expansion, and new senior hires, but noted potential risks tied to macroeconomic uncertainty and sector-specific shocks.
In the coming quarters, the StockStory team will monitor (1) the pace of M&A recovery and whether Corporate Finance volumes continue to outpace historical trends, (2) expansion and productivity gains in EMEA and Asia Pacific following recent senior hires, and (3) sustainability of restructuring activity as macroeconomic conditions evolve. Execution on the acquisition pipeline and integration of new hires will also be key indicators.
Houlihan Lokey currently trades at $197.09, down from $199.93 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free for active Edge members).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Nov-01 | |
| Oct-31 | |
| Oct-31 | |
| Oct-31 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-29 | |
| Oct-28 | |
| Oct-28 | |
| Oct-27 | |
| Oct-23 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite